Location History:
- Rome, IT (1998 - 2014)
- Anzio, IT (2014)
Company Filing History:
2 out of 4 
1 out of 2 
1 out of 3 Years Active: 1998-2014
Title: The Innovations of Maurizio Cianfriglia: A Pioneer in Antibody Development
Introduction
Maurizio Cianfriglia, a notable inventor based in Rome, Italy, has made significant contributions to the field of biotechnology. With a total of three patents to his name, Cianfriglia’s work focuses primarily on innovative antibody derivatives that have promising applications in medicine, particularly in cancer treatment and diagnosis.
Latest Patents
Cianfriglia's latest patents include groundbreaking discoveries in the realm of antibody derivatives. One such patent describes an anti-CEA scFv that maintains a stable Pel B leader sequence, offering high specificity for carcinoembryonic antigen (CEA) and CEACAM1. Such specificity is vital for targeted therapies in oncology. Additionally, he developed a single-chain variable fragment (scFv) that targets the CD99 human protein. This invention is crucial for recognizing an epitope within the extracellular domain of CD99, especially in the context of Ewing sarcoma cells, thus opening avenues for both diagnosis and innovative treatment approaches for this aggressive form of cancer.
Career Highlights
Throughout his career, Cianfriglia has collaborated with esteemed organizations, including the Istituto Superiore Di Sanità and Diatheva S.r.l. His work in these institutions underscores his commitment to advancing healthcare through scientific research and innovation. His patents reflect a deep understanding of antibody technology and its applications in therapeutic areas.
Collaborations
Cianfriglia's contributions have been enhanced through collaborations with talented coworkers like Michela Flego and Alessandro Ascione. These partnerships have resulted in combined expertise that has significantly advanced their shared research goals and the successful development of innovative solutions in biotechnology.
Conclusion
Maurizio Cianfriglia stands out as a key figure in the biotechnology landscape, whose inventions have substantial implications for cancer treatment and diagnostics. His dedication to research and collaboration with industry colleagues highlights the importance of teamwork in driving forward innovations that can ultimately improve patient outcomes. Through his patents, Cianfriglia continues to pave the way for future advancements in the field.